Ingalls & Snyder LLC lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 64,134 shares of the company’s stock after selling 1,558 shares during the period. Ingalls & Snyder LLC’s holdings in AstraZeneca were […]
Hanson & Doremus Investment Management lowered its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,210 shares of the company’s stock after selling 238 shares during the quarter. Hanson & Doremus Investment Management’s holdings […]
First Merchants Corp purchased a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 57,790 shares of the company’s stock, valued at approximately $3,892,000. Other institutional investors and hedge funds have also bought and sold […]
Edmp Inc. cut its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,761 shares of the company’s stock after selling 428 shares during the period. AstraZeneca makes up 1.3% of Edmp […]
First Merchants Corp acquired a new stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 57,790 shares of the company’s stock, valued at approximately $3,892,000. Other large investors have also recently made […]